Zikani Therapeutics Funding: $62M Raised, Series A (2020)
Zikani Therapeutics is based in Watertown, MA. It has raised $62M in total funding. Latest round: Series A.
Zikani Therapeutics funding overview
Zikani Therapeutics is based in Watertown, MA. Zikani Therapeutics has raised $62M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in April 2020. The round record for Zikani Therapeutics runs through 2020; nothing later has been disclosed. Investors on record include Advent Life Sciences, Gurnet Point Capital, Roche Venture Fund. 3 distinct backers are named across the disclosed rounds.
Zikani Therapeutics at a glance
Total raised
$62M
Latest round
Series A
Latest round date
April 2020
Headquarters
Watertown, MA
Notable investors
Advent Life Sciences, Gurnet Point Capital, Roche Venture Fund
Frequently asked about Zikani Therapeutics funding
How much has Zikani Therapeutics raised?
Zikani Therapeutics has raised $62M in total disclosed funding across the rounds on record.
Who has invested in Zikani Therapeutics?
Advent Life Sciences, Gurnet Point Capital, Roche Venture Fund are named among the investors backing Zikani Therapeutics.
What was the latest Zikani Therapeutics funding round?
The most recent disclosed round is a Series A, announced in April 2020.
Where is Zikani Therapeutics based?
Zikani Therapeutics is based in Watertown, MA.
When did Zikani Therapeutics last raise?
The last disclosed Zikani Therapeutics round closed in April 2020 at Series A.
Totals shown for Zikani Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in Watertown and the investors behind them below.
